Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • COVID-19
  • Page 11

Tag: COVID-19

  • BiotechToday
  • World

Antidepressants Turning Organisms Into Zombies

bioxone February 21, 2021February 20, 2021

Thota Kanishka Rao, Amity University Kolkata With the coronavirus pandemic taking over the world, people being locked in their undergoing depression, medical practitioners prescribing Procaz, sounds pretty ok, except for the fact that it might turn fishes into zombies? Researchers have discovered that long-term exposure to the medication makes guppies act all the more indistinguishable. […]

Read More
  • BiotechToday
  • World

D614G: NEW CORONAVIRUS MUTATIONS MAKES THE VIRUS EIGHT TIMES MORE INFECTIOUS

bioxone February 19, 2021February 19, 2021 4

Aishila Kar, Amity University Kolkata The research, confirms findings that D614G — one of many mutations in the concerning variants that have emerged in the UK, South Africa, and Brazil — makes the coronavirus 8times more infectious. This novel coronavirus, D614G mutation in the spike protein renders it up to 8 times more infectious in […]

Read More
  • BiotechToday
  • World

Decreased efficacy of AstraZeneca vaccines on S. African strains

bioxone February 11, 2021February 11, 2021 1

Rohit Bhattacharjee, Amity University, Kolkata. The Oxford/AstraZeneca vaccine fails to prevent mild and moderate cases of the South African coronavirus strain. The University of Witwatersrand, Johannesburg, which conducted the in which they stated that the vaccine provided minimal protection against mild-moderate COVID-19 infection. The data, which has not yet undergone peer review appeared to confirm the theoretical […]

Read More
  • BiotechToday
  • World

COVID-19 Alters Gut Microbiota

bioxone February 10, 2021February 10, 2021 1

Souradip Mallick, National Institute of Technology, Rourkela The global COVID-19 pandemic caused by the novel SARS-CoV-2 is still a threat to the human population. As of February 2020, more than 102 million people globally have been infected, and over 2.21 million deaths reported. COVID-19 pandemic has a profuse impact on the economic as well as […]

Read More
  • BiotechToday
  • World

Main protease enzyme of SARS CoV-2 against COVID-19

bioxone January 21, 2021January 21, 2021 1

-Rohit Bhattacharjee, Amity University Kolkata Coronavirus 2019 – the episode is a worldwide pandemic brought about by (SARS-CoV-2) which at first analyzed in Chinese patients of Hubei’s Wuhan city toward the beginning of December 2019. COVID-19 has been proclaimed a worldwide wellbeing catastrophe by World Health Organization (WHO) as the illness quickly communicated human-to-human and […]

Read More
  • BiotechToday
  • World

AXL receptor: a new companion of the ACE2 receptor which helps SARS-CoV-2 to enter the human body

bioxone January 16, 2021January 16, 2021 1

Parnad Basu, Amity University Kolkata The pandemic caused by COVID-19 is continuing still. The causative viral pathogen of COVID-19 is SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). This SARS-CoV-2 actually belongs to the β coronavirus genus along with SARS-CoV (severe acute respiratory syndrome coronavirus) and MERS-CoV (middle east respiratory syndrome coronavirus). Although SARS-CoV-2 targets the […]

Read More
  • BiotechToday
  • World

Corneal damage induced by the UV from germicidal lamps

bioxone January 12, 2021January 12, 2021 2

Husna, Amity University Kolkata Due to the global outbreak of coronavirus disease (COVID-19) caused by the novel coronavirus SARS-CoV-2, various sanitation strategies have been adopted worldwide so that the spread of the virus and the disease can be prevented.  One such strategy which is adopted for sterilization in offices and homes is the use of […]

Read More
  • BiotechToday
  • World

Mesenchymal Stem Cells Used in SARS-CoV-2 Patients Show Promising Results

bioxone January 11, 2021January 11, 2021 1

Sumedha Guha, Techno India University A ground-breaking randomized trial at the University Of Miami Miller School Of Medicine has given us a new treatment for SARS-CoV-2 patients. In the trial that was led by Dr. Camillo Ricordi, M.D., mesenchymal stem cells of the umbilical cord were infused into the body of patients severely affected by […]

Read More
  • BiotechToday
  • India

COVAXIN : India’s preparation for massive vaccination drive.

bioxone January 10, 2021January 9, 2021

-Chitra Roy, University of Calcutta Covaxin, India’s indigenous COVID-19 vaccine, has been a subject of criticism due to its approval for restricted emergency use despite hot having published any phase 3 efficacy data. However, until recently, Bharat Biotech, the manufacturer of Covaxin claimed that its vaccine potentially generated safety data with the robust immune response […]

Read More
  • Job and Internship
  • Signaling Pathway

COVID-19 Preparedness Scientist (Non-Medical) Recruitment at AIIMS New Delhi

bioxone January 9, 2021January 8, 2021

-Shristi Sharma, Team bioXone AIIMS Delhi Non-Medical Scientist Recruitment – COVID-19 Project. Senior Research Fellow Jobs for microbiology, life sciences, zoology, biostatistics, biotechnology, genetics, or biochemistry applicants. Interested and eligible applicants can check out all of the details on the same below: Infection Prevention and Control (IPC)- Capacity Building- Orientation Training for COVID-19 Preparedness and […]

Read More

Posts navigation

1 … 7 8 9 10 11 12 13 14 15 … 22

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy